Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Immunoglobulin G

From Wikipedia, the free encyclopedia
Antibody isotype
The water-accessible surface area of an IgG antibody

Immunoglobulin G (IgG) is atype ofantibody. Representing approximately 75% ofserum antibodies in humans, IgG is the most common type of antibody found inblood circulation.[1] IgG molecules are created and released byplasma B cells. Each IgG antibody has twoparatopes.

Function

[edit]

Antibodies are major components ofhumoral immunity. IgG is the main type of antibody found inblood andextracellular fluid, allowing it to control infection of bodytissues. By binding many kinds ofpathogens such asviruses,bacteria, andfungi, IgG protects the body from infection.[citation needed]

It does this through several mechanisms:[citation needed]

IgG antibodies are generated followingclass switching and maturation of the antibody response, thus they participate predominantly in thesecondary immune response.[3]

IgG is secreted as a monomer that is small in size allowing it to easilydiffuse into tissues. It is the onlyantibody isotype that hasreceptors to facilitate passage through the humanplacenta, thereby providing protection to thefetusin utero. Along withIgA secreted in thebreast milk, residual IgG absorbed through the placenta provides theneonate with humoral immunity before its ownimmune system develops.Colostrum contains a high percentage of IgG, especially bovine colostrum. In individuals with prior immunity to a pathogen, IgG appears about 24–48 hours after antigenic stimulation.[citation needed]

Therefore, in the first six months of life, the newborn has the same antibodies as the mother and the child can defend itself against all the pathogens that the mother encountered in her life (even if only through vaccination) until these antibodies are degraded. This repertoire of immunoglobulins is crucial for the newborns who are very sensitive to infections, especially within the respiratory and digestive systems.[citation needed]

IgG are also involved in the regulation of allergic reactions. According to Finkelman, there are two pathways of systemicanaphylaxis:[4][5] antigens can cause systemic anaphylaxis in mice through classic pathway by cross-linkingIgE bound to themast cell receptorFcεRI, stimulating the release of bothhistamine andplatelet activating factor (PAF). In the alternative pathway, antigens form complexes with IgG, which then cross-linkmacrophage receptorFcγRIII and stimulates only PAF release.[4]

IgG antibodies can prevent IgE mediated anaphylaxis by intercepting a specific antigen before it binds to mast cell–associated IgE. Consequently, IgG antibodies block systemic anaphylaxis induced by small quantities ofantigen but can mediate systemic anaphylaxis induced by larger quantities.[4]

Structure

[edit]
The various regions and domains of a typical IgG

IgG antibodies are large globular proteins made of four peptide chains;[6] two identical γ (gamma)heavy chains of about 50 kDa and two identicallight chains of about 25 kDa. The resulting tetramericquaternary structure, therefore, has a total molecular weight of about 150 kDa.[7] The two heavy chains are linked to each other and to a light chain each bydisulfide bonds. The resultingtetramer has two identical halves, which together form a Y-like shape. Each end of the fork contains an identicalantigen binding site. The various regions and domains of a typical IgG are depicted in the figure "Anatomy of an IgG."

The Fc regions of IgGs bear a highly conservedN-glycosylation site atasparagine 297 in the constant region of the heavy chain.[8] The N-glycans attached to this site are predominantlycore-fucosylated biantennary structures of the complex type.[9] In addition, small amounts of these N-glycans also bear bisectingGlcNAc and α-2,6-linkedsialic acid residues.[10] The N-glycan composition in IgG has been linked to several autoimmune, infectious and metabolic diseases.[11]

Subclasses

[edit]

There are four IgG subclasses (IgG1, 2, 3, and 4) in humans, named in order of their abundance in serum (IgG1 being the most abundant).[12]

Subclasses of immunoglobulin G
NamePercentageCrossesplacenta easilyComplement activatorBinds toFc receptor on phagocytic cellsHalf life[13]
IgG166%yes (1.47)*second-highesthigh affinity21 days
IgG223%no (0.8)*third-highestextremely low affinity21 days
IgG37%yes (1.17)*highesthigh affinity7 days
IgG44%yes (1.15)*nointermediate affinity21 days
* Quota cord/maternity concentrations blood. Based on data from a Japanese study on 228 mothers.[14]

Note: IgG affinity to Fc receptors on phagocytic cells is specific to individual species from which the antibody comes as well as the class. The structure of the hinge regions (region 6 in the diagram) contributes to the unique biological properties of each of the four IgG classes. Even though there is about 95% similarity between their Fc regions, the structure of the hinge regions is relatively different.[citation needed]

Given the opposing properties of the IgG subclasses (fixing and failing to fix complement; binding and failing to bind FcR), and the fact that the immune response to most antigens includes a mix of all four subclasses, it has been difficult to understand how IgG subclasses can work together to provide protective immunity. In 2013, the Temporal Model of human IgE and IgG function was proposed.[15] This model suggests that IgG3 (and IgE) appear early in a response. The IgG3, though of relatively low affinity, allows IgG-mediated defences to join IgM-mediated defences in clearing foreign antigens. Subsequently, higher affinity IgG1 and IgG2 are produced. The relative balance of these subclasses, in any immune complexes that form, helps determine the strength of the inflammatory processes that follow. Finally, if antigen persists, high affinity IgG4 is produced, which dampens down inflammation by helping to curtail FcR-mediated processes.[citation needed]

The relative ability of different IgG subclasses to fix complement may explain why some anti-donor antibody responses do harm a graft after organ transplantation.[16]

In a mouse model of autoantibody mediated anemia using IgG isotype switch variants of an anti erythrocytes autoantibody, it was found that mouse IgG2a was superior to IgG1 in activating complement. Moreover, it was found that the IgG2a isotype was able to interact very efficiently with FcgammaR. As a result, 20 times higher doses of IgG1, in relationship to IgG2a autoantibodies, were required to induce autoantibody mediated pathology.[17] Since mouse IgG1 and human IgG1 are not entirely similar in function, and the inference of human antibody function from mouse studies must be done with great care. However, both human and mouse antibodies have different abilities to fix complement and to bind toFc receptors.[citation needed]


Class switch

[edit]

Repeatedly administeringCOVID-19 vaccines causes an increase in the proportion of IgG4 antibodies and IgG4-switched B cells, which can lead to impairedcellular phagocytosis andcomplement decomposition function, given that IgG2 and IgG4 play a role of in mediating non-inflammatory or anti-inflammatory functions. After the second vaccine dose, IgG4 accounted for 0.04% of the total IgG response, but after the third vaccine dose, it increased to 19.27%. Also, a significant increase was observed in the proportion of IgG4-producing B cells within thememory B cell pool that bound to the spike protein after the third vaccination.[18]

Role in diagnosis

[edit]
Adalimumab is an IgG antibody.

The measurement of immunoglobulin G can be a diagnostic tool for certain conditions, such asautoimmune hepatitis, if indicated by certain symptoms.[19] Clinically, measured IgG antibody levels are generally considered to be indicative of an individual's immune status to particular pathogens. A common example of this practice are titers drawn to demonstrate serologic immunity to measles, mumps, and rubella (MMR),hepatitis B virus, and varicella (chickenpox), among others.[20]

Testing of IgG is not indicated for diagnosis of allergy, and there is no evidence that it has any relationship to food intolerances.[21][22][23]

See also

[edit]

References

[edit]
  1. ^Vidarsson, Gestur; Dekkers, Gillian; Rispens, Theo (2014)."IgG subclasses and allotypes: from structure to effector functions".Frontiers in Immunology.5: 520.doi:10.3389/fimmu.2014.00520.ISSN 1664-3224.PMC 4202688.PMID 25368619.
  2. ^Mallery DL, McEwan WA, Bidgood SR, Towers GJ, Johnson CM, James LC (2010)."Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)".Proceedings of the National Academy of Sciences, USA.107 (46):19985–19990.Bibcode:2010PNAS..10719985M.doi:10.1073/pnas.1014074107.PMC 2993423.PMID 21045130.
  3. ^Vidarsson, Gestur; Dekkers, Gillian; Rispens, Theo (2014)."IgG subclasses and allotypes: from structure to effector functions".Frontiers in Immunology.5: 520.doi:10.3389/fimmu.2014.00520.ISSN 1664-3224.PMC 4202688.PMID 25368619.
  4. ^abcFinkelman, Fred D. (September 2007). "Anaphylaxis: Lessons from mouse models".Journal of Allergy and Clinical Immunology.120 (3):506–515.doi:10.1016/j.jaci.2007.07.033.PMID 17765751.
  5. ^Khondoun MV, Strait R, Armstrong L, Yanase N, Finkelman FD (2011)."Identification of markers that distinguish IgE-from IgG mediated anaphylaxis".Proceedings of the National Academy of Sciences, USA.108 (30):12413–12418.Bibcode:2011PNAS..10812413K.doi:10.1073/pnas.1105695108.PMC 3145724.PMID 21746933.
  6. ^Janeway CA Jr; Travers P; Walport M; et al. (2001)."Ch3 Antigen Recognition by B-Cell and T-cell Receptors".Immunobiology: The Immune System in Health and Disease (5th ed.). New York: Garland Science.
  7. ^"Antibody Basics".Sigma-Aldrich. Retrieved2014-12-10.
  8. ^Cobb, Brian A. (2019-08-27)."The History of IgG Glycosylation and Where We Are Now".Glycobiology.30 (4):202–213.doi:10.1093/glycob/cwz065.ISSN 1460-2423.PMC 7109348.PMID 31504525.
  9. ^Parekh, R. B.; Dwek, R. A.; Sutton, B. J.; Fernandes, D. L.; Leung, A.; Stanworth, D.; Rademacher, T. W.; Mizuochi, T.; Taniguchi, T.; Matsuta, K. (1–7 August 1985)."Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG".Nature.316 (6027):452–457.Bibcode:1985Natur.316..452P.doi:10.1038/316452a0.ISSN 0028-0836.PMID 3927174.
  10. ^Stadlmann J, Pabst M, Kolarich D, Kunert R, Altmann F (2008). "Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides".Proteomics.8 (14):2858–2871.doi:10.1002/pmic.200700968.PMID 18655055.S2CID 22821543.
  11. ^de Haan, Noortje; Falck, David; Wuhrer, Manfred (2019-07-08)."Monitoring of Immunoglobulin N- and O-glycosylation in Health and Disease".Glycobiology.30 (4):226–240.doi:10.1093/glycob/cwz048.ISSN 1460-2423.PMC 7225405.PMID 31281930.
  12. ^Vidarsson, Gestur; Dekkers, Gillian; Rispens, Theo (2014)."IgG subclasses and allotypes: from structure to effector functions".Frontiers in Immunology.5: 520.doi:10.3389/fimmu.2014.00520.ISSN 1664-3224.PMC 4202688.PMID 25368619.
  13. ^Bonilla FA Immuno Allergy Clin N Am 2008; 803–819
  14. ^Hashira S, Okitsu-Negishi S, Yoshino K (August 2000). "Placental transfer of IgG subclasses in a Japanese population".Pediatrics International.42 (4):337–342.doi:10.1046/j.1442-200x.2000.01245.x.PMID 10986861.S2CID 24750352.
  15. ^Collins, Andrew M.; Katherine J.L. Jackson (2013-08-09)."A temporal model of human IgE and IgG antibody function".Frontiers in Immunology.4: 235.doi:10.3389/fimmu.2013.00235.PMC 3738878.PMID 23950757.
  16. ^Gao, ZH; McAlister, VC; Wright Jr., JR; McAlister, CC; Peltekian, K; MacDonald, AS (2004)."Immunoglobulin-G subclass antidonor reactivity in transplant recipients".Liver Transplantation.10 (8):1055–1059.doi:10.1002/lt.20154.PMID 15390333.
  17. ^Azeredo da Silveira S, Kikuchi S, Fossati-Jimack L, Moll T, Saito T, Verbeek JS, Botto M, Walport MJ, Carroll M, Izui S (2002-03-18)."Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody".Journal of Experimental Medicine.195 (6):665–672.doi:10.1084/jem.20012024.PMC 2193744.PMID 11901193.
  18. ^Irrgang, P., et al. (2022). "Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination".Science Immunology.doi:10.1126/sciimmunol.ade2798.
  19. ^Lakos G, Soós L, Fekete A, Szabó Z, Zeher M, Horváth IF, Dankó K, Kapitány A, Gyetvai A, Szegedi G, Szekanecz Z (Mar–Apr 2008)."Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope".Clinical and Experimental Rheumatology.26 (2):253–260.PMID 18565246. Archived fromthe original on 2014-12-11. Retrieved2014-02-26.
  20. ^Teri Shors (August 2011)."Ch5 Laboratory Diagnosis of Viral Diseases and Working with Viruses in the Research Laboratory".Understanding Viruses (2nd ed.). Jones & Bartlett Publishers. pp. 103–104.ISBN 978-0-7637-8553-6.
  21. ^"Five Things Physicians and Patients Should Question"(PDF).Choosing Wisely. Archived fromthe original(PDF) on November 3, 2012. RetrievedAugust 14, 2012.
  22. ^Cox L, Williams B, Sicherer S, Oppenheimer J, Sher L, Hamilton R, Golden D (2008). "Pearls and pitfalls of allergy diagnostic testing: report from the American College of Allergy, Asthma and Immunology/American Academy of Allergy, Asthma and Immunology Specific IgE Test Task Force".Annals of Allergy, Asthma & Immunology.101 (6):580–592.doi:10.1016/s1081-1206(10)60220-7.PMID 19119701.
  23. ^Stapel, Steven O.; Asero, R.; Ballmer-Weber, B. K.; Knol, E. F.; Strobel, S.; Vieths, S.; Kleine-Tebbe, J.; EAACI Task Force (July 2008). "Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report".Allergy.63 (7):793–796.doi:10.1111/j.1398-9995.2008.01705.x.ISSN 1398-9995.PMID 18489614.S2CID 14061223.

External links

[edit]
Lymphoid
Antigens
Antibodies
Immunity vs.
tolerance
Immunogenetics
Lymphocytes
Substances
Main types
Chains
Retrieved from "https://en.wikipedia.org/w/index.php?title=Immunoglobulin_G&oldid=1338824357"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp